Clinical Trial Update: Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of gemcitabine and vinorelbine in young patients with recurrent or refractory Hodgkin lymphoma has completed recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Lymphoma | Phase 2 | Status: COMPLETED